Recruiting

Anesthetic Techniques Impact on Oxidative Stress in VATS

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This study aims to evaluate how different anesthesia techniques affect oxidative stress levels in patients undergoing video-assisted thoracic surgery, by measuring specific markers in the blood.

What is being tested

Total Intravenous Anesthesia (TIVA) Group

+ Balanced Anesthesia (BAL) Group

+ Combined Intravenous Volatile Anesthesia

Drug
Who is being recruted

From 18 to 65 Years
1 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: December 2025
See protocol details

Summary

Principal SponsorAtaturk University
Study ContactElif Oral Ahiskalioglu, ProfessorMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: December 1, 2025

Actual date on which the first participant was enrolled.

This study is examining how different types of anesthesia affect oxidative stress during lung surgery that involves breathing through only one lung at a time. Oxidative stress is a condition that can cause damage to the body and is a concern during surgeries that involve reintroducing air into a previously non-ventilated lung. The study is focused on patients undergoing video-assisted thoracoscopic surgery, a less invasive type of lung surgery, and aims to find out which anesthetic technique—Total Intravenous Anesthesia (TIVA), Combined Intravenous-Volatile Anesthesia (CIVA), or Balanced Anesthesia (BAL)—is the most effective in reducing oxidative stress and preserving oxygen levels. By evaluating these techniques, the research hopes to improve patient safety and outcomes during such surgeries. Participants in the study will be randomly assigned to one of three anesthesia groups: TIVA, CIVA, or BAL. Each group will receive specific combinations of medications to maintain anesthesia, and their effects will be monitored throughout the surgery. Blood samples will be collected at three key moments: before anesthesia starts, before switching back to normal two-lung ventilation, and 30 minutes after resuming two-lung ventilation. These samples will help measure levels of oxidative stress markers like Malondialdehyde, Superoxide Dismutase, and others. The study will also track heart rate, blood pressure, and other vital signs to assess the overall effects of the anesthesia. Results will be analyzed to determine which method best minimizes oxidative stress and improves surgery outcomes.

Official TitleTotal Intravenous Anesthesia (TIVA), Combined Intravenous-Volatile Anesthesia (CIVA), and Balanced Anesthesia (BAL) on Perioperative Oxidative Stress in Video-Assisted Thoracoscopic Surgery (VATS)
Principal SponsorAtaturk University
Study ContactElif Oral Ahiskalioglu, ProfessorMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

60 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 65 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

1 exclusion criteria prevent from participating
ASA III-IV

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

3 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Anesthesia induction will include 2 mg midazolam, 2-2.5 mg/kg propofol, 0.6-0.9 mg/kg rocuronium, and 1 μg/kg remifentanil. Maintenance will be provided with target-controlled infusion (TCI) propofol at a Ce of 4-6 μg/mL and TCI remifentanil at a Ce of 1.5-3 ng/mL while maintaining the bispectral index (BIS) between 40-60.

Group II

Experimental
Induction will follow the same protocol as the TIVA group. During maintenance, desflurane 5-7% (MAC 1-1.3) and TCI remifentanil at a Ce of 1.5-3 ng/mL will be administered, targeting a BIS value between 40-60.

Group III

Experimental
Induction will follow the same protocol as other groups. Maintenance will include TCI propofol at a Ce of 2-4 μg/mL and TCI remifentanil at a Ce of 1.5-3 ng/mL along with 3% desflurane (MAC 0.5), keeping BIS values between 40-60.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

Ataturk University

Erzurum, Turkey (Türkiye)Open Ataturk University in Google Maps
Recruiting
One Study Center